Neuronatin is a protein that in humans is encoded by the NNAT gene involved in mammalian brain development. It is located on Chromosome 20 in humans and is only expressed from the paternal allele in normal adults.[5]

NNAT
Identifiers
AliasesNNAT, Peg5, neuronatin
External IDsOMIM: 603106; MGI: 104716; HomoloGene: 36176; GeneCards: NNAT; OMA:NNAT - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_181689
NM_005386
NM_001322802

NM_001291128
NM_001291129
NM_001291130
NM_010923
NM_180960

RefSeq (protein)

NP_001309731
NP_005377
NP_859017

NP_001278057
NP_001278058
NP_001278059
NP_035053
NP_851291

Location (UCSC)Chr 20: 37.52 – 37.52 MbChr 2: 157.4 – 157.4 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Function

edit

The protein neuronatin, a proteolipid, that functions in the control of ion channels during brain development. Neuronatin begins the differentiation of pluripotent stem cells into cells with a neural fate by increasing their calcium levels.[6] Neuronatin expression in neural tissues throughout the brain contributes to development of the nervous system. It is also expressed in several tissues outside of the brain. For example, expression in skin cells controls the differentiation of keratinocytes. Neuronatin expression functions not only in development, but other processes throughout the body.

Clinical significance

edit

It also plays a direct and indirect role in diabetes. Increased expression in pancreatic islet beta cells causes the beta form of the protein to build an aggregate structure. This causes the cells to undergo apoptosis, thus leading to diabetes mellitus.[6] Its effects on glycogen metabolism through the dephosphorylation and activation of the enzyme glycogen synthase may also play an indirect role in contributing to the disease. A different type of malformation in the gene also has the potential to cause a variety of cancers. Contained within the promoter region of the gene are three CpG islands. These imprint regions function in the regulation of gene expression through the process of cytosine methylation. The loss of methylation within these areas triggers an irregular cell growth, resulting in embryonic neoplasms.[6]

References

edit
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000053438Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000067786Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Numata S, Ye T, Hyde TM, Guitart-Navarro X, Tao R, Wininger M, et al. (February 2012). "DNA methylation signatures in development and aging of the human prefrontal cortex". American Journal of Human Genetics. 90 (2): 260–272. doi:10.1016/j.ajhg.2011.12.020. PMC 3276664. PMID 22305529.
  6. ^ a b c Joseph RM (15 December 2013). "Neuronatin gene: Imprinted and misfolded: Studies in Lafora disease, diabetes and cancer may implicate NNAT-aggregates as a common downstream participant in neuronal loss". Genomics. 103 (2–3): 183–188. doi:10.1016/j.ygeno.2013.12.001. PMID 24345642.